ERBB2 and neoplasm: Focusing on the filtrate fractions from contralateral mastectomies, we detected no significant difference in proportions of immune cell subsets associated with receptor status (i.e., ER+, HER2+, or TNBC) of the tumor in the affected breast (Fig. 2C).